RuhaAMCanningJ. In response to Mohave rattlesnake envenomation causing allergic myocardial infarction (Kounis syndrome) and neurotoxic respiratory failure by Mookadam et al. Wilderness Environ Med. 2025. In press.
RichardsonWHGotoCSGutglassDJWilliamsSRClarkRF.
Rattlesnake envenomation with neurotoxicity refractory to treatment with crotaline Fab antivenom. Clin Toxicol (Phila).
2007 Jun-Aug;
45(
5):
472–
5.
4.
JansenPWPerkinRMVan StralenD.
Mojave rattlesnake envenomation: prolonged neurotoxicity and rhabdomyolysis. Ann Emerg Med.
1992 Mar;
21(
3):
322–
5.
5.
GopalakrishnakonePHawgoodBJHolbrookeSEMarshNASantana De SaSTuAT.
Sites of action of Mojave toxin isolated from the venom of the Mojave rattlesnake. Br J Pharmacol.
1980 Jul;
69(
3):
421–
31.
6.
KumarSAcevesMGranadosJ, et al.Neurocellular stress response to Mojave type A rattlesnake venom: study of molecular mechanisms using human iPSC-derived neural stem cell model. Biomolecules.
2025 Mar 6;
15(
3):
381.
7.
BosakARRuhaAMGraemeKA.
A case of neurotoxicity following envenomation by the Sidewinder rattlesnake, Crotalus cerastes. J Med Toxicol.
2014 Jun;
10(
2):
229–
31.
8.
FarstadDThomasTChowTBushSStieglerP.
Mojave rattlesnake envenomation in southern California: a review of suspected cases. Wilderness Environ Mede.
1997;
8(
2):
89–
93.
